Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Liapakis

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Advances in Experimental Medicine and Biology|May 18, 2019
Effects of Cholesterol on GPCR Function: Insights from Computational and Experimental StudiesSofia Kiriakidi, Antonios Kolocouris, George Liapakis, et al.
Current Pharmaceutical Design|January 11, 2012
The G-protein coupled receptor family: actors with many facesGeorge Liapakis, Liapakis George, Arnau Cordomí, et al.
The Journal of Biological Chemistry|August 9, 2002
Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switchLei Shi, George Liapakis, Rui Xu, et al.
Biology|February 23, 2024
Structural and Functional Insights into CRF Peptides and Their ReceptorsMinos-Timotheos Matsoukas, Vasilis Panagiotopoulos, Vlasios Karageorgos, et al.
Plos One|May 20, 2014
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytesEirini Dermitzaki, George Liapakis, Ariadne Androulidaki, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 26, 2014
Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulatorsBhimanna Kuppast, Katerina Spyridaki, Christophina Lynch, et al.
Molecules (Basel, Switzerland)|August 10, 2024
Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH)Md Rabiul Islam, Christos Markatos, Ioannis Pirmettis, et al.
Hormones (Athens, Greece)|May 13, 2024
Corticotropin-releasing hormone deficiency results in impaired analgesic response during CFA-induced inflammationEfthymia Karagianni, Olga Rassouli, Smaragda Poulaki, et al.
Experimental Hematology|September 20, 2006
Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropeniaCharalampos Pontikoglou, George Liapakis, Katerina Pyrovolaki, et al.
European Journal of Medicinal Chemistry|November 7, 2012
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological propertiesDespina Laimou, Theodora Katsila, John Matsoukas, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Advances in Experimental Medicine and Biology|May 18, 2019
Effects of Cholesterol on GPCR Function: Insights from Computational and Experimental StudiesSofia Kiriakidi, Antonios Kolocouris, George Liapakis, et al.
Current Pharmaceutical Design|January 11, 2012
The G-protein coupled receptor family: actors with many facesGeorge Liapakis, Liapakis George, Arnau Cordomí, et al.
The Journal of Biological Chemistry|August 9, 2002
Beta2 adrenergic receptor activation. Modulation of the proline kink in transmembrane 6 by a rotamer toggle switchLei Shi, George Liapakis, Rui Xu, et al.
Biology|February 23, 2024
Structural and Functional Insights into CRF Peptides and Their ReceptorsMinos-Timotheos Matsoukas, Vasilis Panagiotopoulos, Vlasios Karageorgos, et al.
Plos One|May 20, 2014
Corticotrophin-Releasing Factor (CRF) and the urocortins are potent regulators of the inflammatory phenotype of human and mouse white adipocytes and the differentiation of mouse 3T3L1 pre-adipocytesEirini Dermitzaki, George Liapakis, Ariadne Androulidaki, et al.
Medicinal Chemistry (Shariqah (United Arab Emirates))|July 26, 2014
Synthesis of new thiazolo[4,5-d]pyrimidines as Corticotropin releasing factor modulatorsBhimanna Kuppast, Katerina Spyridaki, Christophina Lynch, et al.
Molecules (Basel, Switzerland)|August 10, 2024
Design, Synthesis, and Biological Evaluations of Novel Thiazolo[4,5-d]pyrimidine Corticotropin Releasing Factor (CRF) Receptor Antagonists as Potential Treatments for Stress Related Disorders and Congenital Adrenal Hyperplasia (CAH)Md Rabiul Islam, Christos Markatos, Ioannis Pirmettis, et al.
Hormones (Athens, Greece)|May 13, 2024
Corticotropin-releasing hormone deficiency results in impaired analgesic response during CFA-induced inflammationEfthymia Karagianni, Olga Rassouli, Smaragda Poulaki, et al.
Experimental Hematology|September 20, 2006
Evidence for downregulation of erythropoietin receptor in bone marrow erythroid cells of patients with chronic idiopathic neutropeniaCharalampos Pontikoglou, George Liapakis, Katerina Pyrovolaki, et al.
European Journal of Medicinal Chemistry|November 7, 2012
Rationally designed cyclic analogues of luteinizing hormone-releasing hormone: enhanced enzymatic stability and biological propertiesDespina Laimou, Theodora Katsila, John Matsoukas, et al.
Pageof 5